Free Trial

Pacira BioSciences (PCRX) Earnings Date, Estimates & Call Transcripts

Pacira BioSciences logo
$18.98 -0.59 (-3.01%)
(As of 12/20/2024 05:16 PM ET)
Get Pacira BioSciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pacira BioSciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pacira BioSciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.38$0.53$0.46 
Q2 20242$0.51$0.62$0.57 
Q3 20242$0.46$0.49$0.48 
Q4 20242$0.58$0.73$0.66 
FY 20248$1.93$2.37$2.15 
Q1 20251$0.60$0.60$0.60 
Q2 20251$0.58$0.58$0.58 
Q3 20251$0.54$0.54$0.54 
Q4 20251$0.80$0.80$0.80 
FY 20254$2.52$2.52$2.52 
Q1 20261$0.61$0.61$0.61 
Q2 20261$0.63$0.63$0.63 
Q3 20261$0.84$0.84$0.84 

Pacira BioSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/30/2024Q2 2024$0.53$0.64+$0.11$0.89$173.31M$178.02M
5/7/2024Q1 2024$0.46$0.42 -$0.04$0.65$165.43M$167.12M
2/29/2024Q4 2023$0.71$0.71-$0.92$180.60M$181.24M
11/2/2023Q3 2023$0.65$0.52 -$0.13$0.81$172.83M$163.93M
8/2/2023Q2 2023$0.59$0.61+$0.02$0.71$175.64M$169.47M
5/3/2023Q1 2023$0.40$0.32 -$0.08$1.07$157.02M$160.34M
2/28/2023Q4 2022$0.71$0.60 -$0.11$1.42$174.12M$171.96M

Pacira BioSciences Earnings - Frequently Asked Questions

Pacira BioSciences issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $680.0 million-$705.0 million.

Pacira BioSciences (NASDAQ:PCRX) has a recorded annual revenue of $694.96 million.

Pacira BioSciences (NASDAQ:PCRX) has a recorded net income of $41.96 million. PCRX has generated -$2.03 earnings per share over the last four quarters.

Pacira BioSciences's earnings are expected to decrease from $2.32 per share to $2.06 per share in the next year, which is a -11.21% change.

More Earnings Resources from MarketBeat



This page (NASDAQ:PCRX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners